pocketful logo
Gian Lifecare Ltd logo

Gian Lifecare Ltd

NSE: BSE: 542918

₹7.81

(-0.89%)

Sun, 15 Mar 2026, 11:04 pm

mtf coin illustrationMTF 5x

Gian Lifecare Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Unable to evaluate Gian Life Care's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
    • Unable to evaluate Gian Life Care's dividend against the top 25% market benchmark as the company has not reported any payouts.

    health

    thumbs up icon

    Pros

    • Gian Life Care is profitable, therefore cash runway is not a concern.
    • Gian Life Care is profitable, therefore cash runway is not a concern.
    • Debt is well covered by operating cash flow (225.8%, greater than 20% of total debt).
    • Debt is covered by short term assets, assets are 1.1x debt.
    • Gian Life Care's cash and other short term assets cover its long term commitments.
    • Interest payments on debt are well covered by earnings (EBIT is 6.4x coverage).
    thumbs up icon

    Cons

    • Gian Life Care's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
    • Gian Life Care's level of debt (2878.4%) compared to net worth is high (greater than 40%).
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • The average tenure for the Gian Life Care board of directors is less than 3 years, this suggests a new board.
      • The average tenure for the Gian Life Care management team is less than 2 years, this suggests a new team.

      misc

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Gian Life Care is not covered by any analysts.
        • Gian Life Care's last earnings update was 344 days ago.

        past

        thumbs up icon

        Pros

          thumbs up icon

          Cons

          • Gian Life Care used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
          • Whilst Gian Life Care made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%), this is metric is skewed due to its high level of debt.

          value

          thumbs up icon

          Pros

          • Gian Life Care's share price is below the future cash flow value, and at a moderate discount (> 20%).
          • Gian Life Care's share price is below the future cash flow value, and at a substantial discount (> 40%).
          • BSE:542918 is up 6.1% along with the Healthcare industry (5.4%) over the past month.
          thumbs up icon

          Cons

          • Gian Life Care is overvalued based on assets compared to the IN Healthcare industry average.
          • Gian Life Care is overvalued based on earnings compared to the IN Healthcare industry average.
          • Gian Life Care is overvalued based on earnings compared to the India market.
          • BSE:542918 is up 6.1% underperforming the market in India which returned 8% over the past month.

          Open Your Free Demat Account Now!

          Step into a world of zero fees and limitless opportunities!

          pocketful logo

          2022-25 Pocketful. All rights reserved, Built with in India

          Version -5.76

          app image 1app image 2

          Stocks:

          AllABCDEFGHIJKLMNOPQRSTUVWXYZ

          Explore

          Calculatorsfooter arrow down icon
          Popular Calculatorsfooter arrow down icon
          Group Stocksfooter arrow down icon

          Others:

          NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

          Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800